AGENUS INC Reporting Unit, Zero or Negative Carrying Amount, Amount of Allocated Goodwill
AGENUS INC (AGEN) had Reporting Unit, Zero or Negative Carrying Amount, Amount of Allocated Goodwill of $24.10 million as of 2023-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:ReportingUnitZeroOrNegativeCarryingAmountAmountOfAllocatedGoodwill · last filed 2024-03-14
- 2023-12-31: Reporting Unit, Zero or Negative Carrying Amount, Amount of Allocated Goodwill $24.10M.
| Period end | Reporting Unit, Zero or Negative Carrying Amount, Amount of Allocated Goodwill |
|---|---|
| 2023-12-31 | $24.10M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |